Mirabella Financial Services’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,434,387
Closed -$4.12M 287
2025
Q2
$4.12M Sell
3,434,387
-3,106,959
-47% -$3.44M 0.42% 48
2025
Q1
$7.06M Buy
6,541,346
+3,411,156
+109% +$4.79M 0.14% 102
2024
Q4
$5.48M Buy
+3,130,190
New +$5.83M 0.5% 48
2024
Q2
Sell
-215,520
Closed -$584K 573
2024
Q1
$584K Buy
+215,520
New +$520K 0.04% 258

Other funds holding LAB

Mirabella Financial Services's LAB Position: Q3 2025 in Review

Mirabella Financial Services sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 3,434,387 shares — an estimated $4.12M sold.

Mirabella Financial Services first reported a position in LAB in Q1 2024 and held it in 4 quarters. The position peaked at $7.06M in Q1 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

  • Mirabella Financial Services reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
  • Mirabella Financial Services sold 3,434,387 Standard BioTools shares in Q3 2025, an estimated $4.12M.
  • Mirabella Financial Services first reported a position in Standard BioTools in Q1 2024 and held it in 4 quarters.
  • Mirabella Financial Services's Standard BioTools position peaked at $7.06M in Q1 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Mirabella Financial Services's 13F filing for Q3 2025, filed 14 Nov 2025.